The portfolio maintains a cost advantage over competitors, priced within the second-lowest fee quintile among peers.
Victory Trivalent Intl Fd-Core Eq Y MICYX
- NAV / 1-Day Return 7.92 / −0.25 %
- Total Assets 213.5 Mil
-
Adj. Expense Ratio
- Expense Ratio 0.700%
- Distribution Fee Level Below Average
- Share Class Type Institutional
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment 1.0 Mil
- Status Open
- TTM Yield 3.50%
- Turnover 49%
USD | NAV as of Apr 25, 2024 | 1-Day Return as of Apr 25, 2024, 10:14 PM GMT+0
Morningstar’s Analysis MICYX
Will MICYX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 13.7
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk A/S Class B | 2.55 | 5.5 Mil | Healthcare |
Taiwan Semiconductor Manufacturing Co Ltd | 2.10 | 4.6 Mil | Technology |
Novartis AG Registered Shares | 1.53 | 3.3 Mil | Healthcare |
Stellantis NV | 1.35 | 2.9 Mil | Consumer Cyclical |
Siemens AG | 1.28 | 2.8 Mil | Industrials |
Samsung Electronics Co Ltd | 1.22 | 2.6 Mil | Technology |
Holcim Ltd | 0.94 | 2.0 Mil | Basic Materials |
Fairfax Financial Holdings Ltd | 0.93 | 2.0 Mil | Financial Services |
Sumitomo Mitsui Financial Group Inc | 0.93 | 2.0 Mil | Financial Services |
3i Group Ord | 0.92 | 2.0 Mil | Financial Services |